Prospective Comparison Between Continuous Femoral Nerve Block and the Association of Adductor Canal Block and Sciatic Nerve Block in Total Knee Arthroplasty.
试验速览
- 阶段
- 不适用
- 发起方
- 入组人数
- 80
- 主要终点
- Total Opioid-consumption
研究概览
简要总结
The purpose of the study is to determine whether the association of sciatic nerve block to continuous adductor canal block is effective in the treatment of total knee arthroplasty post operative pain .
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomized
- 干预模型
- Parallel
- 主要目的
- Treatment
- 盲法
- Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)
入排标准
- 年龄范围
- 18 Years 至 90 Years（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •Elective unilateral TKA,
- •Planned continuous spinal anesthesia ,
- •Ability to follow study protocol,
- •American Society of Anesthesiologists class 1 to 3.
排除标准
- •Contraindication for neuraxial anesthetic,
- •Chronic opioid use (defined as daily or almost daily use of opioids for >3 months),
- •Hypersensitivity and/or allergies to any of the study medications,
- •Intraoperative use of volatile anesthetics,
- •Preexisting neuropathy on the operative limb,
- •Contraindications to a femoral, adductor canal or Tibial nerve block.
研究组 & 干预措施
Continous femoral nerve block
Patients will receive ultrasound-guided (USG) continuous femoral nerve block with 20 ml ropivacaine 0.2% and USG Continuous adductor canal block with 20 ml of saline and USG infragluteal SNB with 20 ml of saline .
干预措施: Continuous femoral nerve block (Procedure)
Continous femoral nerve block
Patients will receive ultrasound-guided (USG) continuous femoral nerve block with 20 ml ropivacaine 0.2% and USG Continuous adductor canal block with 20 ml of saline and USG infragluteal SNB with 20 ml of saline .
干预措施: Continuous adductor canal block (Procedure)
Continous femoral nerve block
Patients will receive ultrasound-guided (USG) continuous femoral nerve block with 20 ml ropivacaine 0.2% and USG Continuous adductor canal block with 20 ml of saline and USG infragluteal SNB with 20 ml of saline .
干预措施: infragluteal Sciatic nerve block (Procedure)
Continous femoral nerve block
Patients will receive ultrasound-guided (USG) continuous femoral nerve block with 20 ml ropivacaine 0.2% and USG Continuous adductor canal block with 20 ml of saline and USG infragluteal SNB with 20 ml of saline .
干预措施: Ropivacaine 0.2% (Drug)
Continous femoral nerve block
Patients will receive ultrasound-guided (USG) continuous femoral nerve block with 20 ml ropivacaine 0.2% and USG Continuous adductor canal block with 20 ml of saline and USG infragluteal SNB with 20 ml of saline .
干预措施: Saline (Drug)
Continuous adductor canal block
Patients will receive ultrasound-guided continuous adductor canal block with 20 ml ropivacaine 0.2% and USG infragluteal SNB with 20 ml ropivacaine 0.2% and USG continuous FNB with 20 ml of saline .
干预措施: Continuous femoral nerve block (Procedure)
Continuous adductor canal block
Patients will receive ultrasound-guided continuous adductor canal block with 20 ml ropivacaine 0.2% and USG infragluteal SNB with 20 ml ropivacaine 0.2% and USG continuous FNB with 20 ml of saline .
干预措施: Continuous adductor canal block (Procedure)
Continuous adductor canal block
Patients will receive ultrasound-guided continuous adductor canal block with 20 ml ropivacaine 0.2% and USG infragluteal SNB with 20 ml ropivacaine 0.2% and USG continuous FNB with 20 ml of saline .
干预措施: infragluteal Sciatic nerve block (Procedure)
Continuous adductor canal block
Patients will receive ultrasound-guided continuous adductor canal block with 20 ml ropivacaine 0.2% and USG infragluteal SNB with 20 ml ropivacaine 0.2% and USG continuous FNB with 20 ml of saline .
干预措施: Ropivacaine 0.2% (Drug)
Continuous adductor canal block
Patients will receive ultrasound-guided continuous adductor canal block with 20 ml ropivacaine 0.2% and USG infragluteal SNB with 20 ml ropivacaine 0.2% and USG continuous FNB with 20 ml of saline .
干预措施: Saline (Drug)
结局指标
主要结局
Total Opioid-consumption
时间窗: 8 hours postoperative
Cumulative opioid consumption : converting oral, intravenous, and patient-controlled analgesia PCA opioid to morphine equivalent
次要结局
- NRS pain score at rest(0,1,2,4,6,8,12,24 and 48 hours postoperative)
- NRS pain score during movement(0,1,2,4,6,8,12,24 and 48 hours postoperative)
- patient satisfaction(8, 24 and 48 hours postoperative)
- Ability to walk(8, 24 and 48 hours postoperative)
- NRS pain score after 10 meters of walk or maximum walked distance(8, 24 and 48 hours postoperative)
- TUG Test(8, 24 and 48 hours postoperative)
- The 10-m walk test(8, 24 and 48 hours postoperative)
研究者
Rais Karim
Dr
Institut Kassab d'Orthopédie